相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Host-targeting agents for prevention and treatment of chronic hepatitis C - Perspectives and challenges
Mirjam B. Zeisel et al.
JOURNAL OF HEPATOLOGY (2013)
Perspectives and challenges of interferon-free therapy for chronic hepatitis C
Christian M. Lange et al.
JOURNAL OF HEPATOLOGY (2013)
New advances in the molecular biology of hepatitis C virus infection: towards the identification of new treatment targets
Alexander Ploss et al.
GUT (2012)
The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses
Markus Fehrholz et al.
JOURNAL OF GENERAL VIROLOGY (2012)
SAR and Lead Optimization of an HIV-1 Vif-APOBEC3G Axis Inhibitor
Idrees Mohammed et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
Clinical relevance of HCV antiviral drug resistance
C. Welsch et al.
CURRENT OPINION IN VIROLOGY (2012)
Host Apolipoprotein B Messenger RNA-Editing Enzyme Catalytic Polypeptide-Like 3G Is an Innate Defensive Factor and Drug Target Against Hepatitis C Virus
Zong-Gen Peng et al.
HEPATOLOGY (2011)
IL28B polymorphism may guide pegylated interferon plus ribavirin therapy even after curative treatment for hepatitis C virus-related hepatocellular carcinoma
T. Kawaoka et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Heat Stress Cognate 70 Host Protein as a Potential Drug Target against Drug Resistance in Hepatitis B Virus
Yu-Ping Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Small Molecular Compounds that Inhibit Hepatitis C Virus Replication Through Destabilizing Heat Shock Cognate 70 Messenger RNA
Zong-Gen Peng et al.
HEPATOLOGY (2010)
Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G
Shan Cen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
Jean-Pierre Vartanian et al.
PLOS PATHOGENS (2010)
Systematical Optimization of Reverse-Phase Chromatography for Shotgun Proteomics
Ping Xu et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA
Yeshitila N. Friew et al.
RETROVIROLOGY (2009)
Deaminase-Independent Inhibition of Parvoviruses by the APOBEC3A Cytidine Deaminase
Inigo Narvaiza et al.
PLOS PATHOGENS (2009)
Cytidine Deaminases as a Weapon Against Retroviruses and a New Target for Antiviral Therapy
Akifumi Takaori-Kondo et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)
Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications
Lauren G. Holden et al.
NATURE (2008)
Small-molecule inhibition of HIV-1 Vif
Robin Nathans et al.
NATURE BIOTECHNOLOGY (2008)
Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G
David H. Nguyen et al.
JOURNAL OF VIROLOGY (2007)
High expression of APOBEC3G in patients infected with hepatitis C virus
Yoshihiro Komohara et al.
JOURNAL OF MOLECULAR HISTOLOGY (2006)
APOBEC family proteins: Novel antiviral innate immunity
A Takaori-Kondo
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex
XH Yu et al.
SCIENCE (2003)
Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
B Mangeat et al.
NATURE (2003)
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
H Zhang et al.
NATURE (2003)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)